These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8259843)

  • 1. [Hormonal therapy in endometrial cancer].
    Kanoh H; Okudaira Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2306-10. PubMed ID: 8259843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth of endometrial cancer and hormone].
    Kanoh H; Hosono T; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3696-703. PubMed ID: 2531993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal therapy and chemotherapy of endometrial cancer].
    Krauss T; Huschmand H; Hinney B; Viereck V; Emons G
    Zentralbl Gynakol; 2002 Jan; 124(1):45-50. PubMed ID: 11873314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiestrogen therapy of patients with uterine cancer].
    Sugimura M; Terao T
    Nihon Rinsho; 1994 Mar; 52(3):804-8. PubMed ID: 8164386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):447-54. PubMed ID: 8678496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal therapy for endometrial adenocarcinoma].
    Susumu N; Aoki D; Suzuki N; Nozawa S
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):934-45. PubMed ID: 11478142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
    Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
    Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
    Pink D; Lindner T; Mrozek A; Kretzschmar A; Thuss-Patience PC; Dörken B; Reichardt P
    Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone therapy--recent advances].
    Matsumoto K; Noguchi S
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2816-23. PubMed ID: 2959202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy and endocrine therapy of endometrial carcinoma].
    Kanuma T; Matsuzawa M
    Gan No Rinsho; 1990 Aug; 36(10):1161-5. PubMed ID: 2214155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Vereide AB; Kaino T; Sager G; Ørbo A;
    Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-steroid hormones for uterine cancer].
    Komiyama S; Nishio E; Yasue A; Hasegawa K; Udagawa Y
    Nihon Rinsho; 2008 Jan; 66(1):174-81. PubMed ID: 18186261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
    Deppe G; Baumann P; Munkarah A
    Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
    BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
    Gadducci A; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863).
    Beex L; Rose C; Mouridsen H; Jassem J; Nooij M; Estape J; Paridaens R; Piccart M; Gorlia T; Lardenoije S; Baila L
    Eur J Cancer; 2006 Dec; 42(18):3178-85. PubMed ID: 17045796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-dose progesterone therapy in advanced endometrial cancer].
    Lotze W; Richter P; Sarembe B
    Arch Geschwulstforsch; 1982; 52(7):569-74. PubMed ID: 6187310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A trial of biweekly paclitaxel administration in consideration of QOL for advanced or recurrent gynecologic cancer].
    Fushiki H; Yoshimoto H; Ikoma T; Ota S
    Gan To Kagaku Ryoho; 2005 May; 32(5):691-3. PubMed ID: 15918575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.